Data di Pubblicazione:
2022
Abstract:
Anaplastic thyroid cancer (ATC) is one of the most lethal diseases known to humans with a median survival of 5 months. The American Thyroid Association (ATA) recently published guidelines for the treatment of this dreadful thyroid malignancy.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Anaplastic thyroid cancer; Tyrosine-kinase inhibitors; immune checkpoint inhibitors; immunotherapy; targeted therapy; treatment
Elenco autori:
Coca-Pelaz, Andrés; Rodrigo, Juan P; Lopez, Fernando; Shah, Jatin P; Silver, Carl E; Al Ghuzlan, Abir; Menke-van der Houven van Oordt, C Willemien; Smallridge, Robert C; Shaha, Ashok R; Angelos, Peter; Mendenhall, William M; Piazza, Cesare; Olsen, Kerry D; Corry, June; Tufano, Ralph P; Sanabria, Alvaro; Nuyts, Sandra; Nathan, Cherie-Ann; Vander Poorten, Vincent; Dias, Fernando Luiz; Suarez, Carlos; Saba, Nabil F; de Graaf, Pim; Williams, Michelle D; Rinaldo, Alessandra; Ferlito, Alfio
Link alla scheda completa:
Pubblicato in: